Pentacam Changes before and after Phacoemulsification versus Combined Phaco-trabeculectomy - Trial PACTR202108689834812
Access comprehensive clinical trial information for PACTR202108689834812 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Sohag University; Sohag University Hospital and is currently Recruiting. The study focuses on Eye Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sohag University; Sohag University Hospital
Self funded
Timeline & Enrollment
Early Phase 1
Jan 01, 1900
Jan 01, 1900
Summary
Both Phacoemulsification surgery alone and combined Phaco-trabeculectomy have been reported by many authors to be associated with changes in the anatomy and drainage angle of the anterior chamber, Pentacam has potential for safe, noncontact screening of eyes with glaucoma, except for those with plateau iris configurations.7 Also, it provides qualitative and quantitative assessment of the anterior segment structures important to the pathogenesis and the anatomical variations of glaucoma, and the approach to and success of different techniques of surgical intervention. The main objective of our study is to compare anterior segment pentacam changes after phacoemulsification versus combined phaco-trabeculectomy in primary angle-closure glaucoma.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202108689834812
Non-Device Trial